Japan's Otsuka Holds Talks With Korean Government On R&D Project
This article was originally published in PharmAsia News
Executive Summary
SEOUL - The Korean unit of Japan's Otsuka Pharmaceuticals is holding negotiations with South Korea's Ministry for Heath, Welfare and Family Affairs on investing in drug research and development, and the two sides could soon sign a memorandum of understanding, according to a Korea Otsuka executive
You may also be interested in...
Japan's Otsuka Signs MOU To Invest $83 Million In Korea By 2013
SEOUL - Japan's Otsuka Pharmaceuticals signed a memorandum of understanding with Korea's health ministry to invest roughly KRW100 billion ($83 million) in research and development of new drugs as well as for clinical trials over the next five years in Korea
Japan's Otsuka Signs MOU To Invest $83 Million In Korea By 2013
SEOUL - Japan's Otsuka Pharmaceuticals signed a memorandum of understanding with Korea's health ministry to invest roughly KRW100 billion ($83 million) in research and development of new drugs as well as for clinical trials over the next five years in Korea
Multinationals Step Up Clinical Trials In South Korea
SEOUL - More and more multinational companies are coming to South Korea to conduct clinical trials, taking advantage of the country's well-trained workforce, well-established infrastructure, lower cost compared with other advanced countries and competitive R&D capability